Journal of the Association of Nurses in AIDS Care
Volume 21, Issue 6 , Pages 489-502, November 2010

Strategies to Promote Adherence to Antiretroviral Therapy Applied by Dutch HIV Nurse Consultants: A Descriptive Qualitative Study

published online 30 April 2010.

This study describes strategies used by Dutch HIV nurse consultants to promote adherence to antiretroviral therapy (ART) and the assumptions on which these strategies were based. The study used a descriptive qualitative design with individual and focus group interviews. Individual semi-structured interviews (n = 23) focusing on adherence-supporting procedures and case-based focus groups (3 groups with 5-7 participants each) focusing on adherence strategies were held with HIV nurse consultants (n = 19). The strategies described were mainly based on experience. Theoretical principles were rarely discussed and participants seldom referred to the literature. Adherence-promoting strategies were identified for two phases: (a) before beginning ART and (b) during follow-up care while on ART. Strategies that were not used in one specific phase were categorized under “all phases.” Data yielded useful ideas for the care of HIV-infected patients, and findings can be applied to the development and use of adherence-promoting strategies.

Key words: adherence-promoting strategies, focus groups, HIV nurse consultants, individual interviews

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Andy I. M. Hoepelman reports the following relationships: consultancies with Bristol-Myers Squibbb, consultancies and research support with Gilead, consultancies with Novartis, research support and consultancies with Roche, consultancies with Tibotec, and research support and consultancies with Pfizer. The other authors report no real or perceived vested interests that relate to this article (including relationships with pharmaceutical companies, biomedical device manufacturers, grantors, or other entities whose products or services are related to topics covered in this manuscript) that could be construed as a conflict of interest.

PII: S1055-3290(10)00048-8

doi:10.1016/j.jana.2010.03.002

Journal of the Association of Nurses in AIDS Care
Volume 21, Issue 6 , Pages 489-502, November 2010